The United States Pharmacopeia (USP) publishes endotoxin testing recommendations and acceptance criteria
in General Chapter <85> Bacterial Endotoxins Test. USP <85> provides methods and calculation of limits for
drugs. FDA may, as needed, provide additional guidance to clarify the Agency’s current thinking on use of LAL,
recombinant LAL, and other endotoxin testing methods.
